Answers are grounded in this paper and cite their sources.
Purpose: Angiopoietin-2 (Ang-2) is implicated in endothelial dysfunction during sepsis, but its association with neonatal and pediatric sepsis remains insufficiently characterized. This systematic review and meta-analysis compared circulating Ang-2 concentrations in patients with sepsis and non-septic controls. Methods: PubMed/MEDLINE, Embase, Scopus, the Cochrane Central Register of Controlled Trials, and Google Scholar were searched through September 5, 2026. Eleven studies were included in the systematic review. Random-effects meta-analysis pooled standardized mean differences (SMDs). Risk of bias was assessed using the Newcastle–Ottawa Scale, and certainty of evidence using GRADE. Results: Five studies involving 545 participants (460 with sepsis and 85 controls) contributed to the primary meta-analysis. Ang-2 concentrations were higher in patients with sepsis (SMD, 1.54; 95% CI, 0.91–2.18; p < 0.00001), with substantial heterogeneity (I² = 75%). Excluding one study yielded a similar estimate (four studies; SMD, 1.41; 95% CI, 0.74–2.09; I² = 78%). An expanded seven-study sensitivity analysis incorporating graph-derived estimates produced an SMD of 3.86 (95% CI, 2.01–5.70; I² = 97%). Certainty of evidence was very low. Conclusion: Circulating Ang-2 concentrations were elevated in pediatric sepsis compared with non-septic controls. However, substantial heterogeneity and very low-certainty evidence limit clinical interpretation. Further prospective studies are needed to establish its diagnostic and prognostic utility.
No takes yet. Share an insight, caveat, or question.
Khan et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: